Khalid Abubaker

1.3k citations

14 papers · 1.1k indexed · h-index 10

Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 8
Oncology top 5%
- Cancer Cells and Metastasis 8
- Cytokine Signaling Pathways and Interactions 4
- Colorectal Cancer Treatments and Studies 2
Cancer Research top 10%
Neurology top 10%
Molecular Biology
- FOXO transcription factor regulation 2
Biotechnology
- Cancer Research and Treatments 2
Public Health, Environmental and Occupational Health
- Reproductive Biology and Fertility 2
Cellular and Molecular Neuroscience
- Cerebrospinal fluid and hydrocephalus 2

Co-authors: Nuzhat Ahmed Michael Quinn Jock K. Findlay Erik W. Thompson J. K. Findlay Ardian Latifi Rodney B. Luwor Hong‐Jian Zhu
Cited by: Reproductive Medicine Oncology Cancer Research
Journals: Journal of Cellular Biochemistry (2 papers)Current Cancer Drug Targets (1 paper)Frontiers in Oncology (1 paper)
Partner nations: Australia United States Ireland

In The Last Decade

Khalid Abubaker

13 papers receiving 1.1k citations

Peers

Countries citing papers authored by Khalid Abubaker

Since Specialization

Citations

This map shows the geographic impact of Khalid Abubaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Abubaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Abubaker more than expected).

Fields of papers citing papers by Khalid Abubaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Abubaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Abubaker. The network helps show where Khalid Abubaker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Khalid Abubaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Khalid Abubaker Line = papers co-authored together Khalid Abubaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Abstract 5245: Characterization of sub-clonal RAS/BRAF alterations in an anti-EGFR treated advanced CRC cohort using a liquid biopsy-based real world clinical genomics database Cancer Research ·Khalid Abubaker,Danyi Wang,Zheng Feng,Christopher Stroh,Jiemin Liao,Gordon Otto,Коваленко Александр Викторович	2022	1
2	PERSPECTIVE: Tepotinib + cetuximab in patients (pts) with RAS/BRAF wild-type left-sided metastatic colorectal cancer (mCRC) and acquired resistance to anti-EGFR antibody therapy due to MET amplification (METamp). Journal of Clinical Oncology ·Tanios Bekaii‐Saab,Eric Van Cutsem,Antonio Cubillo,Dominic S. P. Leung,Nuria Rodrı́guez-Salas,Kanwal Raghav,Olivier Dupuis,Carlos López,Christophe Tournigand,Nicolás Isambert,Khalid Abubaker,Ziblim Shamsu –Deen,Karin Berghoff,Soetkin Vlassak,Gordon Otto,Josep Tabernero	2021	4
3	Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics Monash University Research Portal (Monash University) ·Khalid Abubaker,Ardian Latifi,Emily Chan,Rodney B. Luwor,Christopher J. Burns,Erik W. Thompson,Jock K. Findlay,Nuzhat Ahmed	2015	7
4	Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem-like cells leading to a reduced tumor burden SHILAP Revista de lepidopterología ·Khalid Abubaker,(unknown),Rodney B. Luwor,(unknown),(unknown),(unknown),Michael Quinn,Erik W. Thompson,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2014	68
5	Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden Frontiers in Oncology ·Khalid Abubaker,Rodney B. Luwor,Ruth M. Escalona,Orla McNally,Michael Quinn,(unknown),Jock K. Findlay,Nuzhat Ahmed	2014	9
6	Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden BMC Cancer ·Khalid Abubaker,Rodney B. Luwor,Hong‐Jian Zhu,Orla McNally,Michael Quinn,Christopher J. Burns,Erik W. Thompson,Jock K. Findlay,Nuzhat Ahmed	2014	103
7	CO₂ Has no Therapeutic Effect on Early Micro Vasospasm after Experimental Subarachnoid Hemorrhage Journal of Cerebral Blood Flow & Metabolism ·Benjamin Friedrich,Mangiagalli Ep,Anna Oniszczuk,Khalid Abubaker,Ewa Koźniewska,Nikolaus Plesnila	2014	26
8	Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets Molecular Aspects of Medicine ·Nuzhat Ahmed,Khalid Abubaker,Jock K. Findlay	2013	71
9	Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden Molecular Cancer ·Khalid Abubaker,Ardian Latifi,Rodney B. Luwor,Simon Nazaretian,Hong‐Jian Zhu,Michael Quinn,Erik W. Thompson,Jock K. Findlay,Nuzhat Ahmed	2013	177
10	Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance Journal of Cellular Biochemistry ·Nuzhat Ahmed,Khalid Abubaker,Jock K. Findlay,Michael Quinn	2012	88
11	Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile Journal of Cellular Biochemistry ·Ardian Latifi,Khalid Abubaker,Mohammad Reza Akbari,Alister C. Ward,Clifford Liongue,M. Husen,Janani Kumar,Erik W. Thompson,Michael Quinn,Jock K. Findlay,Nuzhat Ahmed	2011	212
12	Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts – case series and literature review British Journal of Neurosurgery ·Khalid Abubaker,Zulfiqar Ali,Floyd B. Wilson,Ciarán Bolger,Daniel Rawluk,Donncha F. O’Brien	2011	115
13	Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer Current Cancer Drug Targets ·Nuzhat Ahmed,Khalid Abubaker,J. K. Findlay,Michael Quinn	2010	199
14	Temporal fossa intra-extracranial dumbbell schwannoma British Journal of Neurosurgery ·Limy Wong,Khalid Abubaker,Jane Cryan,Francesca Brett,John Caird	2010	0

About Khalid Abubaker

Khalid Abubaker is a scholar working on Reproductive Medicine, Oncology and Biotechnology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Ovarian cancer diagnosis and treatment (8 papers), Cytokine Signaling Pathways and Interactions (4 papers), Cancer Research and Treatments (2 papers), FOXO transcription factor regulation (2 papers), Reproductive Biology and Fertility (2 papers), Cerebrospinal fluid and hydrocephalus (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Reproductive Medicine (212 citations), Oncology (572 citations) and Cancer Research (308 citations). Khalid Abubaker has collaborated with scholars based in Australia, United States and Ireland. Frequent co-authors include Nuzhat Ahmed, Michael Quinn, Jock K. Findlay, Erik W. Thompson, J. K. Findlay, Ardian Latifi, Rodney B. Luwor, Hong‐Jian Zhu, Simon Nazaretian and Clifford Liongue. Their work appears in journals such as Journal of Cellular Biochemistry, Current Cancer Drug Targets, Frontiers in Oncology, Journal of Clinical Oncology and Molecular Aspects of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact